The Efficacy of Self-Manufactured 40% Dextrose Gel in Asymptomatic Transient Neonatal Hypoglycemia Treatment
Status:
COMPLETED
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to determine the efficacy of 40% dextrose gel therapy as an additional therapy for the management of asymptomatic transient neonatal hypoglycemia in high risk infants
The main question it aims to answer is:
Is 40% dextrose gel effective for the management of asymptomatic transient NH in high risk infants?
Researchers will compare the use of 40% dextrose gel as an additional therapy to the standard treatment and the use of breastmilk or formula milk according standard hypoglycemia treatment only to see if 40% dextrose gel is superior than standard therapy for management as asymptomatic transient NH in high risk infants.
Participants will :
* Receive 40% dextrose gel plus standard therapy or standard therapy only
* Blood glucose level measurement (30 minutes after intervention)
Phase:
PHASE4
Details
Lead Sponsor:
Indonesia University
Collaborators:
Budi Kemuliaan Hospital RS Prof. Dr. I.G.N.G Ngoerah Universitas Indonesia, Cipto Mangunkusumo National General Hospital